home / stock / lmngf / lmngf quote
Last: | $0.239 |
---|---|
Change Percent: | -7.58% |
Open: | $0.2638 |
Close: | $0.239 |
High: | $0.2638 |
Low: | $0.2309 |
Volume: | 649,564 |
Last Trade Date Time: | 04/21/2021 03:05:41 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.239 | $0.2638 | $0.239 | $0.2638 | $0.2309 | 649,564 | 04-21-2021 |
$0.2586 | $0.278649 | $0.2586 | $0.28 | $0.25 | 229,190 | 04-20-2021 |
$0.28 | $0.2772 | $0.28 | $0.3 | $0.276 | 130,423 | 04-19-2021 |
$0.2963 | $0.329 | $0.2963 | $0.329 | $0.28 | 91,032 | 04-16-2021 |
$0.3 | $0.3 | $0.3 | $0.304 | $0.298 | 57,887 | 04-15-2021 |
$0.304 | $0.3346 | $0.304 | $0.34 | $0.304 | 160,744 | 04-14-2021 |
$0.3106 | $0.34 | $0.3106 | $0.34 | $0.3 | 115,560 | 04-13-2021 |
$0.317 | $0.3695 | $0.317 | $0.381 | $0.317 | 132,955 | 04-12-2021 |
$0.35 | $0.34 | $0.35 | $0.3534 | $0.335 | 282,311 | 04-09-2021 |
$0.3356 | $0.295 | $0.3356 | $0.34 | $0.295 | 286,004 | 04-08-2021 |
$0.3013 | $0.28 | $0.3013 | $0.3194 | $0.28 | 244,393 | 04-07-2021 |
$0.295 | $0.29 | $0.295 | $0.3047 | $0.2855 | 61,411 | 04-06-2021 |
$0.305 | $0.3285 | $0.305 | $0.3285 | $0.294 | 91,603 | 04-05-2021 |
$0.3194 | $0.3115 | $0.3194 | $0.3223 | $0.2895 | 140,179 | 04-02-2021 |
$0.3194 | $0.3115 | $0.3194 | $0.3223 | $0.2895 | 140,179 | 04-01-2021 |
$0.3045 | $0.3115 | $0.3045 | $0.3115 | $0.2849 | 91,355 | 03-31-2021 |
$0.3018 | $0.28 | $0.3018 | $0.3133 | $0.28 | 246,803 | 03-30-2021 |
$0.3083 | $0.318265 | $0.3083 | $0.3391 | $0.2968 | 320,035 | 03-29-2021 |
$0.33 | $0.31 | $0.33 | $0.3329 | $0.3 | 159,093 | 03-26-2021 |
$0.3269 | $0.312 | $0.3269 | $0.3433 | $0.309 | 238,947 | 03-25-2021 |
News, Short Squeeze, Breakout and More Instantly...
BioVaxys Technology Company Name:
LMNGF Stock Symbol:
OTCMKTS Market:
BioVaxys Announces New Chief Financial Officer Canada NewsWire VANCOUVER, BC , Sept. 8, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that Mr. Craig Loverock ha...
BioVaxys announces completed synthesis of its Pan-Sarbecovirus Vaccine candidate and launch of in vivo animal study Canada NewsWire VANCOUVER, BC , Sept. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
BIOVAXYS ANNOUNCES COMPLETED DEBT SETTLEMENT Canada NewsWire VANCOUVER, B.C. , Aug. 2, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") further to its news release dated July 4, 2022 , Bi...